133 related articles for article (PubMed ID: 8230095)
1. Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists.
Houlihan WJ; Cheon SH; Parrino VA; Handley DA; Larson DA
J Med Chem; 1993 Oct; 36(21):3098-102. PubMed ID: 8230095
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines.
Houlihan WJ; Munder PG; Handley DA; Cheon SH; Parrino VA
J Med Chem; 1995 Jan; 38(2):234-40. PubMed ID: 7830265
[TBL] [Abstract][Full Text] [Related]
3. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
4. Propenyl carboxamide derivatives as antagonists of platelet activating factor.
Guthrie RW; Kaplan GL; Mennona FA; Tilley JW; Kierstead RW; O'Donnell M; Crowley H; Yaremko B; Welton AF
J Med Chem; 1990 Oct; 33(10):2856-64. PubMed ID: 2170651
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
[TBL] [Abstract][Full Text] [Related]
7. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
Koike H; Imanishi N; Natsume Y; Morooka S
Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
[TBL] [Abstract][Full Text] [Related]
8. Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412.
Handley DA; Van Valen RG; Melden MK; Houlihan WJ; Saunders RN
J Pharmacol Exp Ther; 1988 Nov; 247(2):617-23. PubMed ID: 3183958
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM
J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
[TBL] [Abstract][Full Text] [Related]
10. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
Floch A; Tahraoui L; Sedivy P; Cavero I
J Pharmacol Exp Ther; 1991 Aug; 258(2):567-75. PubMed ID: 1650834
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacology of a novel class of long-lasting PAF receptor antagonists.
Houlihan WJ; Cheon SH; Handley DA; Larson DA
J Lipid Mediat; 1991; 3(1):91-9. PubMed ID: 1662991
[TBL] [Abstract][Full Text] [Related]
12. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist.
Albert DH; Magoc TJ; Tapang P; Luo G; Morgan DW; Curtin M; Sheppard GS; Xu L; Heyman HR; Davidsen SK; Summers JB; Carter GW
Eur J Pharmacol; 1997 Apr; 325(1):69-80. PubMed ID: 9151941
[TBL] [Abstract][Full Text] [Related]
14. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes.
Silva CL; Cruz HN; Violante FA; Cordeiro RS; Martins MA; Noël F
Biochem Pharmacol; 1996 Jan; 51(2):193-6. PubMed ID: 8615889
[TBL] [Abstract][Full Text] [Related]
15. Novel agents combining platelet activating factor (PAF) receptor antagonist with thromboxane synthase inhibitor (TxSI).
Fujita M; Seki T; Inada H; Shimizu K; Takahama A; Sano T
Bioorg Med Chem Lett; 2002 Mar; 12(5):771-4. PubMed ID: 11858999
[TBL] [Abstract][Full Text] [Related]
16. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ro 24-4736 in antagonizing the platelet and bronchoconstrictor responses to PAF.
O'Donnell M
Ann N Y Acad Sci; 1991; 629():416-8. PubMed ID: 1659287
[No Abstract] [Full Text] [Related]
18. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
19. Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor.
Walser A; Flynn T; Mason C; Crowley H; Maresca C; Yaremko B; O'Donnell M
J Med Chem; 1991 Mar; 34(3):1209-21. PubMed ID: 2002463
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
